Transfusion Rates in Total Hip Arthroplasty Are lower in Patients with Direct Anterior Approach

Document Type : RESEARCH PAPER

Authors

1 Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, PA, USA

2 1 Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, PA, USA 2 Cleveland Clinic Florida, Weston, FL, USA

Abstract

Background: Blood conservation and reduction in the need for allogeneic blood transfusion (ABT) has been a subject of importance in total hip arthroplasty. There are a number of well-recognized parameters that influence blood loss during total hip arthroplasty (THA). The role of surgical approach on blood loss and the rate of ABT during THA is not well studied. The hypothesis of this study was that blood loss and the need for ABT is lower with direct anterior (DA) approach. Methods: In a case-control retrospective cohort study, we analyzed 1,524 primary THAs performed at a single institution by seven fellowship-trained surgeons between January 2015 to March 2017. All patients received THA using either the modified direct lateral (DL) or direct anterior (DA) approach using a standard operating table. The overall ABT rate was 10.2% (155/1,524) in the cohort. Demographic, surgical, and postoperative data were extracted and analyzed. Logistic regression was used to identify independent risk factors for transfusion. Results: Higher preoperative hemoglobin (p<0.001), use of DA approach (p<0.016) and administration of tranexamic acid TXA, (p=0.024) were identified as independent factors which reduced the odds of ABT. Operative time (p<0.001) was associated with an increased odd of ABT, while age, BMI and type of anesthesia were not statistically significant. Conclusion: Based on the findings of this study, direct anterior approach for THA appears to be protective against blood loss and reduced ABT rate, when controlling for confounding variables. Level of evidence: III

Keywords

References

1. Learmonth I, Young C, Rorabeck C. The operation of the century: total hip replacement. Lancet 2007;370(9597):1508–19. doi:10.1016/S0140-6736(07)60457-7.
2. Carling MS, Jeppsson A, Eriksson BI, Brisby H. Transfusions and blood loss in total hip and knee arthroplasty: a prospective observational study. J Orthop Surg Res 2015;10:48. doi:10.1186/s13018-015-0188-6.
3. Hart A, Khalil JA, Carli A, Huk O, Zukor D, Antoniou J. Blood Transfusion in Primary Total Hip and Knee Arthroplasty. Incidence, Risk Factors, and Thirty-Day Complication Rates. J Bone Jt Surg 2014;96(23):1945–51. doi:10.2106/JBJS.N.00077.
4. Friedman R, Homering M, Holberg G, Berkowitz SD. Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty. J Bone Joint Surg Am 2014;96(4):272–8. doi:10.2106/JBJS.L.01268.
5. Nichols CI, Vose JG. Comparative Risk of Transfusion and Incremental Total Hospitalization Cost for Primary Unilateral, Bilateral, and Revision Total Knee Arthroplasty Procedures. J Arthroplasty 2016;31(3):583–589.e1. doi:10.1016/j.arth.2015.10.013.
6. Bedard NA, Pugely AJ, Lux NR, Liu SS, Gao Y, Callaghan JJ. Recent Trends in Blood Utilization After Primary Hip and Knee Arthroplasty. J Arthroplasty 2017;32(3):724–7. doi:10.1016/j.arth.2016.09.026.
7. Moskal JT, Capps SG. Meta-analysis of Intravenous Tranexamic Acid in Primary Total Hip Arthroplasty. Orthopedics 2016;39(5):e883–92. doi:10.3928/01477447-20160526-02.
8. Lindman IS, Carlsson L V. Extremely Low Transfusion Rates: Contemporary Primary Total Hip and Knee Arthroplasties. J Arthroplasty 2018;33(1):51–4. doi:10.1016/J.ARTH.2017.07.034.
9. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999;81(1):2–10.
10. Browne JA, Adib F, Brown TE, Novicoff WM. Transfusion rates are increasing following total hip arthroplasty: risk factors and outcomes. J Arthroplasty 2013;28(8 Suppl):34–7. doi:10.1016/j.arth.2013.03.035.
11. Greenky M, Gandhi K, Pulido L, Restrepo C, Parvizi J. Preoperative anemia in total joint arthroplasty: is it associated with periprosthetic joint infection? Clin Orthop Relat Res 2012;470(10):2695–701. doi:10.1007/s11999-012-2435-z.
12. Shander A, Hofmann A, Ozawa S, Theusinger OM, Gombotz H, Spahn DR. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010;50(4):753–65. doi:10.1111/j.1537-2995.2009.02518.x.
13. Nuttall GA, Santrach PJ, Oliver WC, Horlocker TT, Shaughnessy WJ, Cabanela ME, et al. The predictors of red cell transfusions in total hip arthroplasties. Transfusion 1996;36(2):144–9.
14. Park JH, Rasouli MR, Mortazavi SMJ, Tokarski AT, Maltenfort MG, Parvizi J. Predictors of perioperative blood loss in total joint arthroplasty. J Bone Joint Surg Am 2013;95(19):1777–83. doi:10.2106/JBJS.L.01335.
15. Salido JA, Marín LA, Gómez LA, Zorrilla P, Martínez C. Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery: analysis of predictive factors. J Bone Joint Surg Am 2002;84(2):216–20.
16. Klement MR, Peres-Da-Silva A, Nickel BT, Green CL, Wellman SS, Attarian DE, et al. What Should Define Preoperative Anemia in Primary THA? Clin Orthop Relat Res 2017;475(11):2683–91. doi:10.1007/s11999-017-5469-4.
17. Lee G-C, Marconi D. Complications Following Direct Anterior Hip Procedures: Costs to Both Patients and Surgeons. J Arthroplasty 2015;30(9 Suppl):98–101. doi:10.1016/j.arth.2015.03.043.
18. Brooker AF, Bowerman JW, Robinson RA, Riley LH. Ectopic ossification following total hip replacement. Incidence and a method of classification. J Bone Joint Surg Am 1973;55(8):1629–32. 19. Danoff JR, Bobman JT, Cunn G, Murtaugh T, Gorroochurn P, Geller JA, et al. Redefining the Acetabular Component Safe Zone for Posterior Approach Total Hip Arthroplasty. J Arthroplasty 2016;31(2):506–11. doi:10.1016/j.arth.2015.09.010.
20. Chow I, Patel RM, Stulberg SD. Short stem metaphyseal-engaging femoral implants: a case-controlled radiographic and clinical evaluation with eight year follow-up. J Arthroplasty 2015;30(4):600–6. doi:10.1016/j.arth.2014.01.003.
21. Banerjee S, Pivec R, Issa K, Harwin SF, Mont MA, Khanuja HS. Outcomes of short stems in total hip arthroplasty. Orthopedics 2013;36(9):700–7. doi:10.3928/01477447-20130821-06.
22. Parvizi J, Restrepo C, Maltenfort MG. Total Hip Arthroplasty Performed Through Direct Anterior Approach Provides Superior Early Outcome: Results of a Randomized, Prospective Study. Orthop Clin North Am 2016;47(3):497–504. doi:10.1016/j.ocl.2016.03.003.
23. Restrepo C, Parvizi J, Pour AE, Hozack WJ. Prospective randomized study of two surgical approaches for total hip arthroplasty. J Arthroplasty 2010;25(5):671–9.e1. doi:10.1016/j.arth.2010.02.002.
24. Post ZD, Orozco F, Diaz-ledezma C, Hozack WJ, Ong A. Direct Anterior Approach for Total Hip Arthroplasty: Indications, Technique, and Results. J Am Acad Orthop Surg 2014;22(9):595–603.
25. Bender B, Nogler M, Hozack WJ. Direct anterior approach for total hip arthroplasty. Orthop Clin North Am 2009;40(3):321–8. doi:10.1016/j.ocl.2009.01.003.
26. Bergin PF, Doppelt JD, Kephart CJ, Benke MT, Graeter JH, Holmes AS, et al. Comparison of Minimally Invasive Direct Anterior Versus Posterior Total Hip Arthroplasty Based on Inflammation and Muscle Damage Markers. J Bone Jt Surg 2011;93(15):1392–8. doi:10.2106/JBJS.J.00557.
27. Abe H, Sakai T, Takao M, Nishii T, Nakamura N, Sugano N. Difference in Stem Alignment Between the Direct Anterior Approach and the Posterolateral Approach in Total Hip Arthroplasty. J Arthroplasty 2015;30(10):1761–6. doi:10.1016/j.arth.2015.04.026.
28. Parvizi J, Rasouli MR, Jaberi M, Chevrollier G, Vizzi S, Sharkey PF, et al. Does the surgical approach in one stage bilateral total hip arthroplasty affect blood loss? Int Orthop 2013;37(12):2357–62. doi:10.1007/s00264-013-2093-0.
29. Fink B, Mittelstaedt A, Schulz MS, Sebena P, Singer J. Comparison of a minimally invasive posterior approach and the standard posterior approach for total hip arthroplasty A prospective and comparative study. J Orthop Surg Res 2010;5:46.
doi:10.1186/1749-799X-5-46.
30. Alecci V, Valente M, Crucil M, Minerva M, Pellegrino C-M, Sabbadini DD. Comparison of primary total hip replacements performed with a direct anterior approach versus the standard lateral approach: perioperative findings. J Orthop Traumatol 2011;12(3):123–9. doi:10.1007/s10195-011-0144-0.
31. Parvizi J, Gehrke T. Definition of periprosthetic joint infection. J Arthroplasty 2014;29(7):1331. doi:10.1016/j.arth.2014.03.009.
32. Austin MS, Rothman RH. Acetabular orientation: anterolateral approach in the supine position. Clin Orthop Relat Res 2009;467(1):112–8. doi:10.1007/s11999-008-0523-x.
33. Zmistowski B, Karam J a, Durinka JB, Casper DS, Parvizi J. Periprosthetic joint infection increases the risk of one-year mortality. J Bone Joint Surg Am 2013;95(24):2177–84. doi:10.2106/JBJS.L.00789.
34. Bozic KJ, Ries MD. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am 2005;87(8):1746–51. doi:10.2106/JBJS.D.02937.
35. Kapadia BH, McElroy MJ, Issa K, Johnson AJ, Bozic KJ, Mont M a. The economic impact of periprosthetic infections following total knee arthroplasty at a specialized tertiary-care center. J Arthroplasty 2014;29(5):929–32. doi:10.1016/j.arth.2013.09.017.
36. Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J. Periprosthetic joint infection: The incidence, timing, and predisposing factors. Clin Orthop Relat Res 2008;466(7):1710–5. doi:10.1007/s11999-008-0209-4.
37. Poehling-Monaghan KL, Kamath AF, Taunton MJ, Pagnano MW. Direct anterior versus miniposterior THA with the same advanced perioperative protocols: surprising early clinical results. Clin Orthop Relat Res 2015;473(2):623–31. doi:10.1007/s11999-014-3827-z.
38. van Oldenrijk J, Hoogland PVJM, Tuijthof GJM, Corveleijn R, Noordenbos TWH, Schafroth MU. Soft tissue damage after minimally invasive THA. Acta Orthop 2010;81(6):696–702. doi:10.3109/17453674.2010.537804.
39. Sprowls GR, Pruszynski JE, Allen BC. Distribution of Subcutaneous Fat Around the Hip in Relation to Surgical Approach for Total Hip Arthroplasty. J Arthroplasty 2016;31(6):1213–7. doi:10.1016/j.arth.2015.12.015.
40. Sukeik M, Alshryda S, Haddad FS, Mason JM. Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Jt Surg Br 2011;93(1):39–46. doi:10.1302/0301-620X.93B1.
The Archives of Bone and Joint Surgery
Volume 9, Issue 6
November 2021
Pages 659-664

Files

History

  • Receive Date: 25 March 2021
  • Revise Date: 17 August 2021
  • Accept Date: 08 September 2021

Share

How to cite

Statistics